|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,364.00 GBX | +1.87% |
|
+1.87% | +4.16% |
| 06:46pm | Hong Kong-listed Sino Biopharma, AstraZeneca sign respiratory drug deal worth up to $1.9 billion | RE |
| Jul. 07 | Race to launch weight-loss pills heats up as smaller players advance | RE |
| Market Cap | 298B 261B 240B 223B 423B 28,286B 430B 2,882B 1,121B 13,960B 1,119B 1,095B 48,251B | P/E 2026 * |
24x | P/E 2027 * | 21.1x |
|---|---|---|---|---|---|
| Enterprise Value | 317B 278B 256B 237B 450B 30,112B 457B 3,068B 1,193B 14,861B 1,191B 1,165B 51,366B | EV / Sales 2026 * |
5.02x | EV / Sales 2027 * | 4.63x |
| Free-Float |
96.63% | Yield 2026 * |
1.74% | Yield 2027 * | 1.83% |
Last Transcript: AstraZeneca PLC
| 1 day | +1.87% | ||
| 1 week | +1.87% | ||
| Current month | +1.87% | ||
| 1 month | +4.12% | ||
| 3 months | -3.97% | ||
| 6 months | +0.98% | ||
| Current year | +4.16% |
| 1 week | 13,838 |  | 14,686 |
| 1 month | 11,364 | | 15,126 |
| Current year | 11,232 | | 15,732 |
| 1 year | 10,148 | | 15,732 |
| 3 years | 9,461 | | 15,732 |
| 5 years | 8,029 | | 15,732 |
| 10 years | 3,996 | | 15,732 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 2012-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 2021-07-31 |
Jeffrey Pott
CMP | Compliance Officer | - | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 1999-04-05 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 2012-09-30 |
Philip Broadley
BRD | Director/Board Member | 65 | 2017-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Jun. 07 | Free | See Remarks | 1 | 0.0000% | ||
| May. 19 | Sell | See Remarks | -11,893 | 0.0008% | ||
| May. 13 | Fiscal year | Chief Executive Officer | 18,359 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.87% | +1.87% | +40.58% | +42.08% | 292B | |
| +2.96% | +3.01% | +59.87% | +173.31% | 1,070B | |
| +3.05% | +5.23% | +72.11% | +67.81% | 624B | |
| -0.04% | +1.20% | +35.72% | +87.93% | 450B | |
| -2.58% | -2.07% | +27.62% | +22.57% | 328B | |
| +1.36% | +0.17% | +29.90% | +49.33% | 284B | |
| +1.98% | +4.08% | -25.78% | -39.02% | 217B | |
| +0.45% | +1.65% | +25.65% | +68.35% | 198B | |
| +5.21% | +7.93% | +21.99% | +83.23% | 161B | |
| +1.48% | -0.04% | -4.64% | -32.25% | 135B | |
| Average | +0.95% | +1.67% | +28.30% | +52.33% | 375.95B | |
| Weighted average by Cap. | +1.53% | +1.65% | +41.75% | +83.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.19B 55.3B 50.97B 47.24B 89.67B 5,998B 91.12B 611B 238B 2,960B 237B 232B 10,231B | 66.85B 58.5B 53.91B 49.97B 94.86B 6,345B 96.39B 646B 251B 3,131B 251B 246B 10,823B |
| Net income | 12.45B 10.9B 10.04B 9.31B 17.67B 1,182B 17.95B 120B 46.83B 583B 46.75B 45.74B 2,016B | 13.96B 12.22B 11.26B 10.44B 19.81B 1,325B 20.13B 135B 52.5B 654B 52.41B 51.28B 2,260B |
| Net Debt | 19.24B 16.83B 15.51B 14.38B 27.3B 1,826B 27.74B 186B 72.34B 901B 72.22B 70.65B 3,114B | 11.71B 10.25B 9.44B 8.75B 16.62B 1,111B 16.88B 113B 44.04B 549B 43.96B 43.01B 1,896B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-07 | GBX 14,364.00 | +1.87% | 1,528,247 |
| 26-07-06 | GBX 14,100.00 | -2.46% | 2,008,204 |
| 26-07-03 | GBX 14,456.00 | -0.56% | 653,264 |
| 26-07-02 | GBX 14,538.00 | +4.94% | 2,810,574 |
| 26-07-01 | GBX 13,854.00 | -1.74% | 1,804,499 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
